for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Pfizer raises profit outlook

Strong sales of Prevnar helped the drug maker more than double its quarterly profit. As Fred Katayama reports, one analyst called the results "refreshingly boring."

最新のビデオ
エンタテインメント
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up